Skip to main content

Politicians make promises on their stump — we watch and hold them accountable.

Help keep the record honest →Create an account
Bills/119th Congress · Senate

S.Res. 436

Introduced

A resolution expressing support for the designation of September 2025 as "National Prostate Cancer Awareness Month".

Sponsor
RMike Crapo· Idaho
Introduced
October 6, 2025
Policy area
Health
Latest action
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S6959; text: CR S6958-6959)October 6, 2025
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 436 Agreed to Senate (ATS)]

<DOC>

119th CONGRESS
1st Session
S. RES. 436

Expressing support for the designation of September 2025 as ``National 
Prostate Cancer Awareness Month''.

_______________________________________________________________________

IN THE SENATE OF THE UNITED STATES

October 6, 2025

Mr. Crapo (for himself, Mr. Booker, Mr. Risch, and Mr. Van Hollen) 
submitted the following resolution; which was considered and agreed to

_______________________________________________________________________

RESOLUTION

Expressing support for the designation of September 2025 as ``National 
Prostate Cancer Awareness Month''.

Whereas more than 3,300,000 men are living with prostate cancer in the United 
States;
Whereas 1 in 8 men in the United States will be diagnosed with prostate cancer 
in their lifetimes and 1 in 41 men in the United States will die from 
prostate cancer;
Whereas prostate cancer is the most commonly diagnosed non-skin cancer and the 
second-leading cause of cancer-related deaths among men in the United 
States;
Whereas the American Cancer Society estimates that, in 2025, 313,780 men will be 
diagnosed with, and more than 35,770 men will die of, prostate cancer;
Whereas 35 percent of newly diagnosed prostate cancer cases occur in men under 
the age of 65;
Whereas the odds of developing prostate cancer rise rapidly after age 50;
Whereas having a father or brother with prostate cancer more than doubles the 
risk of a man developing prostate cancer, with a higher risk for men who 
have a brother with the disease and the highest risk for men with 
several affected relatives;
Whereas screening by a digital rectal examination and a prostate-specific 
antigen blood test may be able to detect the disease at an early stage;
Whereas, when diagnosed with localized- or regional-stage prostate cancer, the 
survival rate nears 100 percent;
Whereas only 37 percent of men survive more than 5 years if diagnosed with 
prostate cancer after the cancer has metastasized;
Whereas there are typically no noticeable symptoms of prostate cancer in the 
early stages, making discussions with a doctor regarding appropriate 
screening critical;
Whereas, in fiscal year 2025, Congress appropriated $48,551,000,000 to the 
National Institutes of Health, including $7,220,000,000 for the National 
Cancer Institute;
Whereas, in fiscal year 2025, Congress appropriated $75,000,000 for the Prostate 
Cancer Research Program of the Department of Defense;
Whereas the Department of Veterans Affairs has established 21 Precision Oncology 
Centers of Excellence in order to deliver precision oncology services to 
veterans suffering from prostate cancer;
Whereas ongoing research promises further improvements in prostate cancer 
prevention, early detection, and treatment; and
Whereas educating individuals in the United States, including health care 
providers, about prostate cancer and early detection strategies while 
emphasizing the importance of consultation with a physician regarding 
the benefits and risks of screening is essential to saving lives and 
preserving and protecting families: Now, therefore, be it
Resolved, That the Senate--
(1) expresses support for the designation of ``National 
Prostate Cancer Awareness Month'';
(2) declares that steps should be taken--
(A) to raise awareness about the importance of 
screening methods for, and treatment of, prostate 
cancer;
(B) to encourage research--
(i) to improve screening and treatment for 
prostate cancer;
(ii) to discover the causes of prostate 
cancer; and
(iii) to develop a cure for prostate 
cancer; and
(C) to continue to consider ways to improve access 
to, and the quality of, health care services for 
detecting and treating prostate cancer; and
(3) calls on the people of the United States, interest 
groups, and affected persons--
(A) to promote awareness of prostate cancer;
(B) to take an active role in the fight to end the 
devastating effects of prostate cancer on individuals, 
families, and the economy; and
(C) to observe National Prostate Cancer Awareness 
Month with appropriate ceremonies and activities.
<all>

Plain-language analysis

Not yet analyzed.

A plain-language breakdown — including any hidden or off-intent provisions and whether the bill was fast-tracked — is generated separately and reviewed before publishing. It will appear here once ready. Until then, the verbatim text above and the official source are the record.

StumpWatch is live, and the record is still growing. Many promises and positions aren’t tracked yet, and some features are still in beta. Add a sourced promise and help keep the record honest.

Help keep the record honest →